CTNNB1 and neoplasm: GSK3 has been shown to play a central role in mediating anti-tumor immune responses, although the prominent role of GSK3 in the (APC)-beta-catenin destruction complex implies that an inhibition of GSK3 could trigger tumor promotion by activating β-catenin [8–9].